Centiva Capital’s iShares Biotechnology ETF IBB Stock Holding History

Centiva Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,600	Closed	-$608K	–	1803
2024 Q4	$608K	Sell	4,600 -4,800	-51%	-$675K	0.01%	715
2024 Q3	$1.37M	Sell	9,400 -25,800	-73%	-$3.73M	0.03%	663
2024 Q2	$4.83M	Buy	+35,200	New	+$4.7M	0.08%	161
2024 Q1	–	Sell	-2,400	Closed	-$326K	–	1971
2023 Q4	$326K	Buy	+2,400	New	+$293K	0.01%	1166
2021 Q1	–	Sell	-75,000	Closed	-$11.4M	–	1267
2020 Q4	$11.4M	Hold	75,000	–	–	0.44%	39
2020 Q3	$10.2M	Hold	75,000	–	–	0.67%	24
2020 Q2	$10.3M	Sell	75,000 -244,900	-77%	-$31.2M	0.62%	24
2020 Q1	$34.5M	Buy	319,900 +71,400	+29%	+$8.22M	1.55%	6
2019 Q4	$30M	Buy	248,500 +244,900	+6,803%	+$27.3M	1.46%	11
2019 Q3	$358K	Sell	3,600 -1,400	-28%	-$147K	0.02%	401
2019 Q2	$546K	Sell	5,000 -5,000	-50%	-$532K	0.03%	256
2019 Q1	$1.12M	Sell	10,000 -4,400	-31%	-$483K	0.08%	169
2018 Q4	$1.39M	Buy	14,400 +10,000	+227%	+$1.06M	0.11%	122
2018 Q3	$536K	Buy	+4,400	New	+$518K	0.05%	126

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Centiva Capital's IBB Position: Q1 2026 in Review

Centiva Capital opened a new position in iShares Biotechnology ETF (IBB) in Q1 2026: 3,000 shares worth $507K. The stake represents ﹤0.01% of the portfolio and ranks #832 among its holdings. This is a return to the name: Centiva Capital previously reported a position in IBB as recently as Q4 2024.

Centiva Capital first reported a position in IBB in Q4 2018 and has held it in 13 quarters since. The position peaked at $17.6M in Q1 2020. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Centiva Capital held 3,000 shares of iShares Biotechnology ETF worth $507K as of Q1 2026.
iShares Biotechnology ETF was a new Centiva Capital position in Q1 2026.
iShares Biotechnology ETF made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #832 holding.
Centiva Capital first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 13 quarters since.
Centiva Capital's iShares Biotechnology ETF position peaked at $17.6M in Q1 2020.
919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.